ELRIG Networking Event: Artificial Intelligence in drug discovery

Add to your list(s) Download to your calendar using vCal

• Andreas Bender (University of Cambridge); Adam Corrigan (AZ); Andrea Taddei (BenevolentAI)
• Wednesday 20 March 2019, 17:30-20:00
• Cancer Research UK Cambridge Institute.

If you have a question about this talk, please contact Benjamin Taylor.

Artificial Intelligence and machine learning are promised to transform every aspect of modern research, from the bench to the bedside. What is the truth behind these revolutionary claims and how far will AI impact on daily scientific exploration?

Join us for this ELRIG Networking meeting where we will explore how these technologies are already being used across different disciplines of drug discovery research. We’ve speakers from across academia, biotech and industry who will offer their unique insights into where AI will lead us and what the future reality holds.

Confirmed Speakers

Andreas Bender (Group leader at the Centre for Molecular Informatics, Department of Chemistry, University of Cambridge) ‘Algorithms in Drug Discovery – From Hype to Reality’

Adam Corrigan (Senior Research Scientists, Discovery Sciences IMED , AstraZeneca) ‘Revolutionising Cellular Screening with Artificial Intelligence’

Andrea Taddei (Mechanistic Area Lead, BenevolentAI)

Following the presentations, there will be a complimentary food and drinks reception, giving further networking opportunities. We look forward to welcoming you to Cambridge on the 20th of March.

More details here: ELRIG Networking

Registration here: Register

This talk is part of the ELRIG series.

This talk is included in these lists:

• Cancer Research UK Cambridge Institute

Note that ex-directory lists are not shown.